BCR-ABL tyrosine kinase inhibitors

244 Pill - yellow round

Pill with imprint 244 is Yellow, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-244-100 mg-Yellow-Round

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: 244
Strength: 100 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 70771-1394
Inactive Ingredients:
Latest News
Related Drugs